Acrivon Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2021 | 17.4M |
| FY2022 | 20.6M |
| FY2023 | 22.1M |
| FY2024 | 33.8M |
| FY2025 | 38.5M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2021 | 17.4M |
| FY2022 | 20.6M |
| FY2023 | 22.1M |
| FY2024 | 33.8M |
| FY2025 | 38.5M |